References
- Moolgavkar S. H. Biological models of carcinogenesis and quantitative risk assessment. Risk Analysi 1994; 14: 879
- Crump K. S. Limitations of biological models of carcinogenesis for low-dose extrapolation. Risk Analysi 1994; 14: 883
- Andersen M. E., Clewell H. J., III, Gargas M. L., Smith F. A., Reitz R. H. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Pharmacol 1987; 87: 185
- Gaylor D. W. Risk estimation-an overview: Disease risk estimation based upon animal bioassays. Drug Metab. Rev. 1996, this issue
- Portier C. J., Edler L. Two-stage models of carcinogenesis, classification of agents, and design of experiments. Fundam. Appl. Toxicol 1990; 14: 444
- Lensing S. Y., Kodell R. L. Fitting the two-stage clonal expansion model based on exact hazard using SAS NLIN. Risk Analysi 1995; 15: 233–245